Shattuck Labs, Inc.

STTK Healthcare Biotechnology

In the quarter to June 2026, revenue fell 10.3%, EPS grew 50.0% and free cash flow grew 1.01%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years; insiders bought in the last twelve months.

5.42 0.11 −1.99%
Market cap
$555.0M
P/E
0.0×
Fwd P/E
−10.3×
Dividend yield
—
F-score
4/9
Altman Z
10.16
Beneish M
n/a
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
P/E ratio
— — — 0.00

+8 more quarters

P/S ratio
— — — 30.77
P/FCF ratio
— — — 0.00
P/Operating CF
— — — (19.32)
P/B ratio
— — — 1.85
Price to Tangible BV
— — — 1.85
EV/Sales
— — — 15.41
EV/EBITDA
— — — 0.00
EV/Operating CF
— — — (1.77)
EV/FCF
— — — (1.77)
Quick Ratio
26.94 21.28 11.07 16.14
Current Ratio
27.59 22.06 11.70 17.00
Net Debt/EBITDA
13.44 6.15 6.12 8.64
Debt/Assets
0.00% 0.00% 0.00% 0.00%
Debt/Equity
0.00 0.00 0.00 0.00
Asset Turnover
0.00 0.00 0.00 0.05
Operating CF/Net income
0.67 0.91 0.67 0.89
Capex/Depreciation
(0.21) 0.00 0.00 (0.09)
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 761.80%
Selling, General and Administrative Expense of Revenue
0.00% 0.00% 0.00% 409.80%
Intangible Assets out of Total Assets
0.00 0.00 0.00 0.00
Share Based Compensation of Revenue
0.00% 0.00% 0.00% 177.80%
Graham Net Nets
— — — 0.48
Graham Number
— — — 0.00
Earnings Yield
— — — (42.68%)
Free Cash Flow Yield
— — — (28.34%)
Revenue per Share
0.00 0.00 0.00 0.01
Operating CF per Share
(0.08) (0.12) (0.12) (0.12)
Capex per Share
0.00 0.00 0.00 0.00
Free Cash Flow per Share
(0.08) (0.12) (0.12) (0.12)
Cash per Share
1.61 0.81 1.12 1.19
Shareholders Equity per Share
1.63 0.85 1.18 1.29
Interest Debt per Share
0.00 0.00 0.00 0.00
Book value per Share
1.63 0.85 1.18 1.29
Free Cash Flow
(10.33) (13.42) (8.49) (9.00)
Working Capital
205.54 89.50 75.42 85.39
Capital Expenditures
(0.14) — 0.00 (0.07)
Net Current Asset Value
203.74 87.47 73.84 83.63
EV/EBIT
— — — 0.00
Capex to Sales
0.00 — 0.00 0.07
Price to Operating Income
— — — 0.00
Other line items
Average Payables
2.21 1.39 2.26 2.04
Average Assets
142.52 89.64 91.04 106.03
Average Common Equity
134.08 81.71 81.01 94.91

Fold the line items

Columns are period end dates